CVA Family Office’s Nomura Holdings NMR Stock Holding History

CVA Family Office’s Portfolio NMR Stock Details NMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06K	Buy	+135	New	+$1.16K	﹤0.01%	1640

Other funds holding NMR

DSC

Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CVA Family Office's NMR Position: Q1 2026 in Review

CVA Family Office opened a new position in Nomura Holdings (NMR) in Q1 2026: 135 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #1640 among its holdings.

271 funds tracked by Wall St. Rank hold NMR as of Q1 2026.

CVA Family Office held 135 shares of Nomura Holdings worth $1.06K as of Q1 2026.
Nomura Holdings was a new CVA Family Office position in Q1 2026.
Nomura Holdings made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1640 holding.
271 funds tracked by Wall St. Rank held Nomura Holdings as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.